California's High-Speed Rail project is facing challenges, with costs currently $100 billion over budget. This video examines ...

Aiming to facilitate large-scale indigenous manufacturing, this device will secure regulatory approvals, and facilitate the ...

At 78 years old, Maria has high blood pressure and needs to take seven different medications throughout the day at specific ...

Survived a heart attack Find out how the right medications lifestyle changes and monitoring can help you live well even with ...

The new IQ9N-3P microinverter utilizes gallium nitride technology to deliver 427 VA of peak power and 97.5% efficiency for the 480 V three-phase commercial market.

Impulse Dynamics®, a global medical device company committed to improving the lives of people with heart failure (HF), ...

Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and ...

In advanced dry disease, a key problem is failure of retinal pigment epithelium, often shortened to RPE. These cells help ...

SynCardia Systems will work with design firm Hydrix on the development of the Emperor, a next-gen, fully implantable Total ...

Bayer to acquire AT-01 & AT-05, investigational molecular imaging agents for the diagnosis of cardiac amyloidosis from Attralus: Berlin, Germany Wednesday, January 14, 2026, 11:00 ...

Instructure’s Melissa Loble explains why readiness beats buzzwords, and how AI, tech fluency, and safe failure can prepare ...

Bayer, looking to bolster its position in both imaging and cardiac medicine, struck a deal to snap up two experimental imaging agents and thereby enter the diagnostic tracers development space. | ...